摘要
目的:通过观察胃肠康定胶囊对NSAIDs所致大鼠胃黏膜损伤模型6-keto-PGF1α、PGE2表达的影响,探讨其粘膜保护作用机制。方法:雄性Wistar大鼠48只随机分为空白对照组、模型对照组、奥美拉唑阳性对照组、胃肠康定大、中、小剂量治疗组6组,各组均灌胃给药,给予不同处理7d后处死全部大鼠。放免法检测胃黏膜组织6-keto-PGF1α、PGE2的表达,并进行统计学处理。结果:胃肠康定胶囊各剂量组均能上调NSAIDs所致大鼠胃黏膜损伤模型中6-keto-PGF1α、PGE2的表达,减轻NSAIDs所致大鼠胃黏膜损伤模型胃黏膜的损伤程度。结论:胃肠康定胶囊对NSAIDs所致大鼠胃黏膜损伤具有保护作用,其作用机理与提高6-keto-PGF1α、PGE2的表达有关。
Objective:To observe the Effect of Wei Chang Kang Ding Capsule on 6-keto-PGF1α and PGE2 expression in gastric mucosal injury model of rats induced by NSAIDs and to explore its mechanisms.Methods:48 male Wistar rats were divided into six groups randomly,normal control group,modelgroup,positive medicine group,high-dosage group,normal-dosage group,low-dosage group.Except for the normal control group,the rest groups were administrated correspondent drugs,7 days after administration,6-keto-PGF1α and PGE2 content of rats were detected by RIA.Results: The expression of 6-keto-PGF1α and PGE2 level of rats were significantly increased in Wei Chang Kang Ding groups.Conclusion:Wei Chang Kang Ding capsule could reduce the degree of gastric mucosa injury induced by NSAIDs by increasing the expression of 6-keto-PGF1a and PGE2 in rats,which could be one of the mechanisms of Wei Chang Kang Ding capsule in protecting gastric mucosa induced by NSAIDs.
出处
《中国中医基础医学杂志》
CAS
CSCD
北大核心
2011年第4期393-395,共3页
JOURNAL OF BASIC CHINESE MEDICINE
基金
山西省卫生厅科技攻关项目(200115)